Neridronic acid vs infliximab in patients with ankylosing spondylitis

Trial Profile

Neridronic acid vs infliximab in patients with ankylosing spondylitis

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Sep 2013

At a glance

  • Drugs Neridronic acid (Primary) ; Infliximab
  • Indications Ankylosing spondylitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Sep 2013 Results published in Rheumatology.
    • 23 Jun 2013 New trial record
    • 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top